Prurigo nodularis of hyde treated with low-dose thalidomide

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 2, 2009, Pages 141-145

  Orlando, A ^a   Renna, Sara ^a   Cottone, M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Hyde; Low dose; Prurigo nodularis; Pruritic lesions; Skin nodules; Thalidomide

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN; EMOLLIENT AGENT; PREDNISONE; THALIDOMIDE;

ADULT; ARTICLE; CASE REPORT; DERMATITIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; NAUSEA; PERIPHERAL NEUROPATHY; PRURIGO; PRURIGO NODULARIS OF HYDE; QUALITY OF LIFE; REMISSION; SKIN DEFECT; SKIN NODULE; SKIN SCAR; UNSPECIFIED SIDE EFFECT;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PRURIGO; THALIDOMIDE; TREATMENT OUTCOME;

EID: 65649123842     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. LEE MR, SHUMACK S. Prurigo nodularis: A review. Australas J Dermatol 2005; 46: 211-220.
2. ACCIOLY-FILHO JW, NOGUEIRA A, RAMOS-E-SILVA M. Prurigo nodularis of Hyde: An update. J Eur Acad Dermatol Venereol 2000; 14: 75-82.
3. MIYACHI Y, OKAMOTO H, FURUKAWA F, IMAMURA S. Prurigo nodularis: A possibile relationship to atopy. J Dermatol (Tokyo) 1980; 7: 281-283.
4. HENG MC, ALLEN SG, KIM A, LIEBERMAN J. Alpha-1-antitrypsin deficiency in a patient with widespread prurigo nodularis. Australas J Dermatol 1991; 32: 151-157.
5. ROWLAND PAYNE CM, WILKINSON JD, MCKEE PH, JURECKA W, BLACK MM. Nodular prurigo - a clinico-pathological study of 46 patients.. Br J Dermatol 1985; 113: 431-439.
6. NERI S, RACIN C, D'ANGELO G, IERNA D, BRUNO CM. Hyde's prurigo nodularis and chronic HCV hepatitis. J Hepatol 1998; 28: 161-164.
7. MCKENZIE AW, STUBBING DG, ELVY BL. Prurigo nodularis and gluten enteropathy. Br J Dermatol 1976; 95: 89-92.
8. GOODWIN PG. Nodular prurigo associated with gluten enteropathy. Proc R Soc Med 1977; 70: 140-141.
9. FINA L, GRIMALT R, BERTI E, CAPUTO R. Nodular prurigo associated with Hodgkin's disease. Dermatologica 1991; 182: 243-246.
10. SHELNITZ LS, PALLER AS. Hodgkin's disease manifesting as prurigo nodularis. Pediatr Dermatol 1990; 7: 136-139.
11. RUNNE U, ORFANOS CE. Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo. Arch Dermatol 1977; 113: 787-791.
12. NAHASS G, PENNEYS NS. Merkel cells and prurigo nodularis. J Am Acad Dermatol 1994; 31: 86-88.
13. PEREZ GL, PETERS MS, REDA AM, BUTTERFIELD JH, PETERSON EA, LEIFERMAN KM. Mast cells, neutrophils, and eosinophils in prurigo nodularis. Arch Dermatol 1993; 129: 861-865.
14. MEYERS LN. Use of occlusive membrane in the treatment of prurigo nodularis. Int J Dermatol 1989; 28: 275-276.
15. VAATAINEN N, HANNUKSELA M, KARVONEN J. Local photochemotherapy in nodular prurigo. Acta Derm Venereol 1979; 59: 544-547.
16. HANN SY, CHO MY, PARK Y-K. UV treatment of generalized prurigo nodularis. Int J Dermatol 1990; 29: 436-437.
17. WALDINGER TP, WONG RC, TAYLOR WB, VOORHEES JJ. Cryotherapy improves prurigo nodularis. Arch Dermatol 1984; 120: 1598-1600.
18. STANDER S, LUGER T, METZE D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001; 44: 471-478.
19. SHESKIN J. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965; 6: 303-306
20. WU JJ, HUANG DB, PANG KR, HSU S, TYRING SK. Thalidomide: dermatological indications, mechanisms of action and side effects. Br J Dermatol 2005; 153: 254-273.
21. PAGHDAL KV, SCHWARTZ R. Thalidomide and its dermatologic uses. Acta Dermatovenerol Croat 2007; 15: 39-44.
22. WINKELMANN RK, CONNOLLY SM, DOYLE JA, PADILHA-GONCALVES A. Thalidomide treatment of prurigo nodularis. Acta Derm Venereol 1984; 64: 412-417.
23. JOHNKE H, ZACHARIAE H. Thalidomide treatment of prurigo nodularis. Ugeskr Laeger 1993; 155: 3028-3030.
24. BIELSA I, TEIXIDÓ J, RIBERA M, FERRÁNDIZ C. Erythroderma due to thalidomide: Report of two cases. Dermatology 1994; 189: 179-181.
25. FERRÁNDIZ C, CARRASCOSA JM, JUST M, BIELSA I, RIBERA M. Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis. Dermatology 1997; 195: 359-361.
26. CROUCH RB, FOLEY PA, BAKER CS. Thalidomide experience of a major Australian teaching hospital. Australas J Dermatol 2002; 43: 278-284.
27. MAURER T, PONCELET A, BERGER T. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: Efficacy and risk of neuropathy. Arch Dermatol 2004; 140: 845-849.
28. ALFADLEY A, AL-HAWSAWI K, THESTRUP-PEDERSEN K, AL-ABOUD K. Treatment of prurigo nodularis with thalidomide: A case report and review of the literature. Int J Dermatol 2003; 42: 372-375.
29. LAN CC, LIN CL, WU CS, CHAI CY CHEN WT, CHEN GS. Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide. J Dermatol 2007; 34: 237-242.